FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

horizonal rule

FDA PUBLIC CALENDAR

Food and Drug Administration
Office of Public Affairs
5600 Fishers Lane
Rockville, MD 20857

This public calendar is issued by the Food and Drug Administration. It lists meetings held by the FDA policy makers with persons outside the executive branch of the Federal Government.

fdalogo

April 11, 2005

fdalogo

FDA Official and Title

Date and Site

Other FDA Participants

Non-FDA Participants

Subject

Gerald F. Masoudi, Acting Chief Counsel 4/4/05 FDA Rockville Jeff Shuren, OP and William McConagha, OCC Michael E. Peppel, Dr. Krishna S. Vishnupad, NeuroSci, Inc.; John Serio, Brown, Rudnick, Berlack, Israels Comb. Drug/Diet Supp Products
Gerald F. Masoudi, Acting Chief Counsel 4/7/05 FDLI/Washington, D.C. None None Spoke at Annual FDLI Meeting
Marsha B. Henderson, MCRP, Acting Assistant Commissioner for Women's Health Office of Women's Health (OWH) 4/7/05 FDA Rockville Margaret Miller, PhD, DABT, RN, Scientific Programs Manager, OWH and Susana Perry, MS, BS, Health Programs Coordinator, OWH Phyllis Greenberger, MSW, President & CEO, Society for Women's Health Research (SWHR); Sherry marts, PhD, Vice President, Scientific Affairs, SWHR; Martha Nolan, JD, Vice President, Public Policy, SWHR; and L. Jo Parrish, MA, MBA, Vice President, Institutional Advancement, SWHR To discuss collaborations with OWH regarding health education campaigns
Jesse L. Goodman, MD, MPH, Director, CBER 4/6-8/05 Washington, DC Unknown Conference attendees and Food and Drug Law Institute (FDLI) Annual Meeting CBER Update on various biologics issues
Jesse L. Goodman, MD, MPH, Director, CBER 4/4-5/05 Washington, DC Unknown; Staff from CBER Office of Vaccines Research and Review Conference attendees; LaMontagne Memorial Symposium on Pandemic Influenza Research at National Academy of Sciences in conjunction with IOM and WHO Talk entitled "Meeting the Challenge of pandemic Vaccine Preparedness: An FDA Perspective"

horizonal rule